US appeals court upholds AstraZeneca’s Seroquel XR patent

19-02-2013

The US Court of Appeals for the Federal Circuit has affirmed a 2012 ruling that AstraZeneca’s patent for blockbuster antipsychotic drug Seroquel XR is valid and has been infringed by companies selling competing generics.


AstraZeneca, Seroquel XR, Mylan, Torrent, Osmotica, infringement

WIPR